ANDA 219670, held by Annora Pharma. Desogestrel; Ethinyl Estradiol.
As of Nov 15, 2026, ANDA 219670 (Desogestrel And Ethinyl Estradiol), held by Annora Pharma, was first approved by FDA on Jul 7, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 7, 2026 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Desogestrel And Ethinyl Estradiol0.15MG,N/A;0.02MG,0.01MG ยท tablet;oral-28 | Desogestrel; Ethinyl Estradiol | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
